Palleos Healthcare Gmbh

This study tested if giving an immunotherapy drug (atezolizumab) alone for two weeks before starting standard chemotherapy was better than starting both treatments together. It involved 442 people with triple-negative breast cancer, a hard-to-treat type, before they had surgery. …

This study tested whether a smartphone app could help people with HER2-positive breast cancer better manage side effects during chemotherapy. About 196 participants were randomly assigned to either use the app alongside their normal treatment or receive normal treatment alone. Th…